Study on messaging heart failure doctors in Amsterdam
Part of Heart & circulation clinical trials.
This trial tests if sending reminders to doctors can improve care for people with heart failure with reduced pumping function. It aims to help patients get the best treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are being treated for heart failure with reduced pumping function at a cardiology clinic.
- Your heart's pumping strength (ejection fraction) is less than 40%, confirmed by an ultrasound or MRI.
- You have not opted out of having your medical data used for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests tools to help doctors and patients work together to start or adjust heart failure medicines. You may qualify if your heart's pumping strength is low and you are missing certain recommended medications.
This study follows people with heart failure in Vietnam to understand their health and treatment over time. It does not test a new drug—just collects information to improve care.
This study tests whether sending guidance messages to your cardiologist improves how heart failure care is provided. It may help patients get the right medication plan, if they are not already on the strongest versions of the standard treatments.
This study looks at how well doctors follow guidelines when treating people with heart failure and a reduced pumping ability. You will continue your usual care for one year, and researchers will track your progress to improve heart failure treatment.
This study tests whether teaching heart failure patients about their medications through WhatsApp messages helps them take their drugs as prescribed and manage their symptoms better. You'll receive medication training based on a nursing model designed to support your daily management.
This study tests whether messages from a large language model (a type of AI) can help doctors prescribe the right medicines for heart failure. It may help people with heart failure get the best guideline-recommended treatments.
Hear when a new Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.